Stay updated on Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedRevision tag at the bottom of the page updated from v3.6.2 to v3.6.3, reflecting a new version of the page.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, signaling a newer release. This reflects a minor update or bug fix rather than a change to study details or user-facing content.SummaryDifference0.1%

- Check43 days agoChange DetectedNew navigation items were added for How to Read a Study Record, Common Questions, and How to Join a Study, and the Intervention/Treatment label was introduced. The old Intervention / Treatment label and the prior revision note (v3.5.5) were removed.SummaryDifference0.5%

- Check50 days agoChange DetectedThe page's revision tag was updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a newer edition of the page was published.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision metadata on the page was updated from v3.5.3 to v3.5.4, signifying a new version of the page. There are no changes to the study content or user-facing data indicated by this update.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page’s footer/site release revision was updated from v3.5.2 to v3.5.3, indicating a platform or template version change rather than a modification to the study record.SummaryDifference0.1%

Stay in the know with updates to Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.